HIMSS20 In Orlando
See how CoverMyMeds solves medication access challenges for patients every step of the way with the only end-to-end prescription decision support solution.March 9-13, 2020
Prescription Decision Support
Equipping providers and their staff with the right data to make the best prescribing choice.
We’re taking meaningful patient consultation beyond the point of prescribing by integrating the latest in real-time benefit check technology and the nation’s leading electronic prior authorization solution directly into the administrative workflow.Schedule a Demo
Education Track Session:
Prescription Decision Support at the Point of Prescribing
As enrollment in high-deductible health care plans increases, high prescription costs are becoming the new norm for many patients. This medication price hike can lead to prescription abandonment, ultimately endangering patient health. In 2018 alone, an estimated 140 million prescriptions were abandoned.1 This session will outline why prescribers need cost-transparency functionality, the different implementation models available in EHRs and highlights from a recent case study that illustrate how one implementation model led to fewer surprises at the pharmacy and better therapy adherence.
Miranda Gill, MSN, RN, NEA-BC
Director of Clinical Innovation, CoverMyMeds
Eric Weidmann, MD
Chief Medical Officer of eMDs
- Shrank WH, Choudhry NK, Fischer MA, Avorn JA, Powell M, Schneeweiss S, Liberman JN, Dollear T, Brennan TA, Brookhart MA. The Epidemiology of Prescriptions Abandoned at the Pharmacy. Ann Intern Med. 2010;153(10):633-640. QuintilesIMS. National Prescription Audit. Parsippany, NJ: QuintilesIMS Institute; 2016